Concepedia

Yi Hong

YH

Statistics

Publications

4

Citations

166

H-Index

4

Active since

2021

Affiliations

Nanjing University of Chinese Medicine(Current)

China Medical University

Soochow University

Yi Hong is an author at Nanjing University of Chinese Medicine specializing in inflammation, pharmacology, and innate immunity.

Publications per year

2021–2023

4

Publications

4

BRD4 PROTAC degrader ARV-825 inhibits T-cell acute lymphoblastic leukemia by targeting 'Undruggable' Myc-pathway genes

Shuiyan Wu, You Jiang, Yi Hong et al. · Cancer Cell International · 2021 · 71 citations · Full text

, , +16

Puerarin protects against sepsis-associated encephalopathy by inhibiting NLRP3/Caspase-1/GSDMD pyroptosis pathway and reducing blood-brain barrier damage

Shuang Zhou, Yuhua Li, Yi Hong et al. · European Journal of Pharmacology · 2023 · 42 citations · Full text

, , +17

Lipoxin A4 protects against paraquat‑induced acute lung injury by inhibiting the TLR4/MyD88‑mediated activation of the NF‑κB and PI3K/AKT pathways

Yuhua Li, Na Wang, Zhongliang Ma et al. · International Journal of Molecular Medicine · 2021 · 29 citations · Full text

, , +17

Sepsis Inflammation Impairs the Generation of Functional Dendritic Cells by Targeting Their Progenitors

Jie Lu, Kun Sun, Huiping Yang et al. · Frontiers in Immunology · 2021 · 24 citations · Full text

, , +17

1–4 of 4